| Patents > Guidance, Tools, and Manuals > Classification > Class Schedule |
|
|
|
| Class Numbers & Titles | Class Numbers Only | USPC Index | International | HELP |
|
| You are viewing a USPC Schedule. |
|
![[Search a list of Patent Appplications for class 536]](../as.gif) Class 536 | ORGANIC COMPOUNDS -- PART OF THE CLASS 532-570 SERIES |
| Click here for a printable version of this file | |
| This Class 536 is considered to be an integral part of Class 260 (see the Class 260 schedule for the position of this Class in schedule hierarchy). This Class retains all pertinent definitions and class lines of Class 260. | ||
| ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1) |
![[List of Patents for class 536 subclass 1.11]](../ps.gif) | 1.11 |  Carbohydrates or derivatives |
| | 2 |  Pectin or derivative |
| | 3 | Algin or derivative |
| | 4.1 | O- or S- Glycosides |
| | 4.4 |  Aescin or derivative |
| | 5 | Cyclopentanohydrophenanthrene ring system |
| | 6 |  Oxygen containing six-membered hetero ring (e.g., oxathiane, etc.) |
| | 6.1 | Oxygen containing five-membered hetero ring |
| | 6.4 | Daunomycin or derivative |
| | 6.5 | Oxygen containing hetero ring having at least twenty members (e.g., amphotericin, nystatin, pimaricin, etc.) |
| | 7.1 | Oxygen containing hetero ring having 12-19 members (e.g., methymycin, carbomycin, spiramycin, etc.) |
| | 8 | Flavon sugar compounds |
| | 8.8 | Coumermycin or derivative |
| | 13 | Novobiocin or derivative |
| | 13.1 | Antibiotic BM 123 or derivative |
| | 13.2 | Neomycin B or neomycin C or derivative |
| | 13.3 | Paromomycin or derivative (e.g., neomycin E, etc.) |
| | 13.4 | Antibiotic XK or derivative |
| | 13.5 | Butirosin or derivative (e.g., ambutyrosin, etc.) |
| | 13.6 | Gentamicin or derivative |
| | 13.7 | Kanamycin or derivative |
| | 13.9 | Sisomicin or derivative |
| | 14 | Streptomycin or derivative |
| | 16.1 | Fortimicin or derivative |
| | 16.2 | Lincomycin or derivative |
| | 16.3 | Cyano or -COO- containing |
| | 16.4 | Additional sulfur containing |
| | 16.5 | Phosphorus or halogen containing |
| | 16.6 | Neamine or derivative (e.g., neomycin A, etc.) |
| | 16.7 | Kasugamycin or derivative |
| | 16.8 | Antibiotics |
| | 17.1 | Boron, phosphorus, heavy metal or aluminum containing |
| | 17.2 | Nitrogen containing |
| | 17.3 | Nitrogen containing hetero ring |
| | 17.5 | Sulfur containing (e.g., methylthiolincosaminide, etc.) |
| | 17.7 | Nitro or nitroso containing |
| | 17.9 | Nitrogen in aglycone moiety |
| | 18.1 | Polycyclo ring system (e.g., hellebrin, etc.) |
| | 18.2 | Containing -C(=X)X- wherein the X's are the same or diverse chalcogens |
| | 18.3 | Plural oxyalkylene groups bonded directly to each other |
| | 18.4 | Halogen containing |
| | 18.5 | Processes |
| | 18.7 | Nitrogen containing |
| | 20 | Chitin or derivative |
| | 21 | Heparin or derivative |
| | 22.1 | N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) |
| | 23.1 | DNA or RNA fragments or modified forms thereof (e.g., genes, etc.) |
| | 23.2 |  Encodes an enzyme |
| | 23.4 | Encodes a fusion protein |
| | 23.5 | Encodes an animal polypeptide |
| | 23.6 | Encodes a plant polypeptide |
| | 23.7 | Encodes a microbial polypeptide |
| | 24.1 | Non-coding sequences which control transcription or translation processes (e.g., promoters, operators, enhancers, ribosome binding sites, etc.) |
| | 24.2 | Non-coding sequences having no known regulatory function which are adaptors or linkers for vector or gene contruction |
| | 24.3 | Probes for detection of specific nucleotide sequences or primers for the synthesis of DNA or RNA |
| | 24.31 |  Probes for detection of animal nucleotide sequences |
| | 24.32 | Probes for detection of microbial nucleotide sequences |
| | 24.33 | Primers |
| | 24.5 | Nucleic acid expression inhibitors |
| | 25.1 | 3`-5` linked RNA |
| | 25.2 | 2`-5` linked RNA |
| | 25.3 | Synthesis of polynucleotides or oligonucleotides |
| | 25.31 | Deprotection step |
| | 25.32 | Labels or markers utilized (e.g., radiotracer, affinity, fluoroescent, phosphorescent, markers, etc.) |
| | 25.33 | Pentavalent phosphorus compound utilized |
| | 25.34 | Trivalent phosphorus compound utilized |
| | 25.4 | Separation or purification of polynucleotides or oligonucleotides |
| | 25.5 | Homopolymers having repeating sequences of four or more identical nucleotide units |
| | 25.6 | Nucleic acids which include two or three nucleotide units |
| | 26.1 | Phosphorus containing N-glycoside wherein the N is part of an N-hetero ring |
| | 26.11 | The phosphorus is part of a ring |
| | 26.12 | The N-hetero ring is part of a purine ring system |
| | 26.14 | The N-hetero ring is a diazine or a diazole ring, including hydrogenated |
| | 26.2 | Plural phosphorus atoms in N-glycoside |
| | 26.21 | Plural phosphorus atoms bonded directly to the same chalcogen in a chain (e.g., pyrophosphates, polyanhydrides of phosphorus acids, etc.) |
| | 26.22 |  Both terminal phosphorus atoms are esterified by organic groups wherein one of these organic groups is the sugar moiety |
| | 26.26 | Triphosphates (in same chain) |
| | 26.3 | |
